When AR42J cells, an amylase-secreting pancreatic exocrine cell line, were treated with activin A, cells extended neuritelike processes, and, concomitantly, amylase-contaiing vesicles disappeared. Immunofluorescence and immunoelectron microscopy revealed that these processes had neurite-specific cytoskeletal architectures: neurofilaments and microtubule bundles with cross-bridges of microtubuleassociated protein 2. In addition to such morphological changes, activin-treated cells exhibited a marked increase in cytoplasmic free calcium concentration in response to depolarizing concentration of potassium. Moreover, activintreated AR42J cells expressed mRNA for al subunit of the neuroendocrine/(8 cell-type voltage-dependent calcium channel. In naive AR42J cells, a sulfonylurea compound, tolbutamide, did not affect free calcium concentration, while it induced a marked elevation of free calcium in activintreated cells. Single channel recording of the membrane patch revealed the existence of ATP-sensitive potassium channel in activin-treated cells. These results indicate that activin A converts amylase-secreting AR42J cells to neuronlike cells. Given that pancreatic endocrine cells possess neuronlike properties and express ATP-sensitive potassium channel as well as neuroendocrine/fl cell-type voltage-dependent calcium channel, activin treatment of AR42J cells may provide an in vitro model system to study the conversion of pancreatic exocrine cells to endocrine cells in islets. (J. Clin. Invest. 1995. 95:2304-2314
Introduction
Activin A is a homodimeric protein with a molecular mass of 25 kD originally isolated from ovarian fluid as a stimulant for follicle-stimulating hormone secretion ( 1) . Based on its molecular structure, activin A is considered to be a member of the diverse actions of activin A on cellular growth and differentiation in various types of cells. Activin A increases the number of gonadotrophs in anterior pituitary cultures (3) and modulates differentiation of ovarian granulosa cells (4) . In addition to its action on the pituitary-gonadal axis, activin A also induces differentiation of erythroid cells (5, 6) and megakaryocytes (7) , inhibits hepatocyte proliferation (8) , modifies growth and differentiation of neuronal cells (9, 10) , and acts as an inducer of mesoderm during development (11, 12) . More recently, it is reported that blockade of activin receptor signaling promotes neuralization in Xenopus embryo (13) .
We have shown recently that activin A inhibits amylase secretion and cell proliferation in rat pancreatic acinar AR42J cells in culture (14) . These cells are derived from the chemically induced rat pancreatic acinar carcinoma and are widely used for studies on the regulation of exocrine secretion. It is interesting to note that AR42J cells also possess some properties characteristic of neuroendocrine cells. For example, these cells have electrically excitable membranes ( 15 ) and express synaptophysin, a marker of neuronal cells (16) . Hence, these cells are considered to be amphicrine, expressing both exocrine and neuroendocrine functions (16) . Logsdon et al. (17) reported that AR42J cells become differentiated in response to dexamethasone. Thus, dexamethasone blocks cell growth, augments amylase biosynthesis, and increases the number of secretory granules. When activin A is added together with dexamethasone, the action of dexamethasone is attenuated: Activin A blocks dexamethasone-induced elevation of amylase content, and secretory granules disappear in activin-treated cells (14) . It is noteworthy that when activin A alone is added, it completely blocks proliferation of AR42J cells, and amylase content becomes undetectable. This raises the possibility that activin A induces differentiation to a direction different from that induced by dexamethasone. Given that AR42J cells are amphicrine cells and that activin A is a modulator of differentiation in a variety of cells, including endocrine and neuronal cells ( 13 ), it is interesting to determine whether or not activin A affects the neuroendocrine property of AR42J cells. In the present study, we examined the effect of activin A on the morphology and function of AR42J cells. We report here that activin A converts AR42J cells into neuronlike cells.
Methods
Cell culture. AR42J cells provided by Professor Toshiyuki Takeuchi (Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan) were maintained in DME containing 20 mM Hepes/ NaOH (pH 7.4), 5 mM NaHCO3, penicillin, streptomycin, and 10% FCS. Since commercially available FCS contains various amounts of activin A depending upon the lot (up to 2 nM), we checked the bioactiv-(Flow Laboratories, North Ryde, Australia) in this study. For all experiments, cells were plated at a density of 4 X 105 cells/ml with or without 4 nM activin A. PLC/PRF/5 cells, a human hepatoma cell line (18) , were supplied by the Foundation for Promotion of Cancer Research (Tokyo, Japan) and cultured as described above.
Antibodies. The neurofilaments were prepared from rat brain and purified with hydroxyapatite gel and DE-52 column chromatography as described by Liem and Hutchinson ( 19) . Purified 160-kD neurofilament (NF)' protein was mixed with CFA and injected into rabbits. The rabbits received three booster shots of 160-kD NF protein mixed with incomplete Freund's adjuvant at 14-d intervals. On the third day after the third booster, the rabbits were bled, and this serum was affinitypurified using a 160-kD neurofilament protein-bound triopropyl Sepharose 6B affinity column (Sigma Chemical Co., St. Louis, MO). The affinity-purified rabbit polyclonal antibody against rat brain microtubule-associated protein 2 (MAP-2), kindly provided by Professor Yasuo Ihara (Department of Neuropathology, University of Tokyo School of Medicine, Tokyo, Japan), specifically reacts with MAP-2 and does not cross-react with other microtubule-associated proteins (20 Immunoblotting. For immunoblotting of MAP-2 and NF, AR42J cells or rat brains were homogenized in buffer A (100 mM Pipes, pH 6.6, 1 mM EGTA, 1 mM MgSO4, 1 mM PMSF, and 10 mg/ml leupeptin). The homogenate was centrifuged at 180,000 g for 90 min at 2°C. The resulting crude extracts were fractionated on 6% SDS-polyacrylamide gels according to the method of Laemmli (21 ) and electrophoretically transferred to Immobilon (Millipore Corp., Bedford, MA). For immunoblotting of synaptophysin, crude extracts of activin A-treated and untreated cells were prepared by the method of Drubin et al. (22) . Protein concentration was determined by the method of Lowry et al. (23) . The same amount of protein (90 ,ug) was applied to each lane of 10% SDS-polyacrylamide gels and fractionated and transferred to Immobilon as described above.
Immunofluorescence microscopy. Cells were cultured on noncoated glass coverslips at a cell density described above. Cells were fixed with 3% paraformaldehyde in PBS, treated with 0.1% (vol/vol) Triton X-100 in PBS for 5 min, and incubated sequentially with Blocking Ace (Morinaga, Tokyo, Japan), first antibody, and indocarbocyanine-conjugated donkey anti-rabbit IgG or tetramethylrhodamine isothiocyanateconjugated goat anti-mouse IgG. The (25) . In this method, a DNA competitor, which was synthesized by deleting 42 bp from the neuroendocrine/p cell-type VDCC al subunit cDNA by site-directed mutagenesis and which had the same primer sequences as the neuroendocrine/,6 cell-type VDCC al subunit, was used as an internal standard. This competitor was kindly provided by Dr. Jun Takeda (University of Chicago, Chicago, IL). We used this competitor as an internal standard, and we could distinguish the competitor from the authentic reverse transcript because of the difference in sizes. The difference in efficiency of PCR between reaction tubes was corrected. Double-stranded cDNA of AR42J cells was synthesized from poly(A) RNA obtained by using the Quick Prep Kit (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). Rat islet cDNA library, kindly provided by Professor Kazuhiko Tatemoto (Institute for Molecular and Cellular Regulation, Gunma University), was used as a control template. Oligonucleotide primers were designed on the basis of neuroendocrine/ ,6 cell-type VDCC al-subunit cDNA sequence (26) . The sense and antisense primers were 5 '-ATTGCTGTAGACAATTTGGCT-3' and 5 '-AGCAGGAACCTCAGGCTCGT-3', respectively. The sizes of PCR products from neuroendocrine//3 cell-type VDCC al subunit and its competitor were 276 bp and 234 bp, respectively. The reactions were conducted in a DNA Thermal Cycler (Perkin-Elmer Corp., Norwalk, CT) with the following cycle of conditions: denaturation at 94°C for 1 min, annealing at 58°C for 1 min, and extension at 72°C for 1 min. The number of cycles was 30. The products were separated on an 8% polyacrylamide gel and visualized with ethidium bromide.
Measurement of cytoplasmic free calcium concentration ([Ca2+ ]c).
Cells were grown on a glass coverslip and treated with or without activin A. Cells were then loaded with a calcium-sensitive fluorescent dye, fura-2, by incubating with 2 tzM fura-2/acetoxymethylester for 30 min at room temperature. The fura-2-loaded cells were applied on a fluorescent microscope, and fluorescence from a single cell was monitored as described previously (27).
[Ca2+]c was estimated assuming an even distribution of free calcium in cytosol (27).
Conversion of Exocrine Cells to Neuronlike Cells (28) . The pipette solution contained 150 mM NaCi, 5 mM KC1, 1 mM MgCI2, 2 mM CaCl2, and 10 mM Hepes/ NaOH (pH 7.4). High resolution membrane currents were recorded using a patch clamp amplifier (EPC-9; HEKE, Lambrecht, Germany) controlled by the "E9 screen" software on an Atari (Sunnyvale, CA) computer. Membrane potential was clamped at 0 mV. K+ channel openings were seen as inward currents and conventionally displayed as downward deflections in the records. The bath solution contained 150 mM KC1, 1 mM MgCl2, 5 mM EGTA, and 10 mM Hepes/KOH (pH 7.2).
VDCC was measured by the perforated mode of patch clamp technique (29) . The extracellular solution contained 115 mM NaCl, 5 mM CsCl, 1 mM MgCl2, 10 mM BaCl2, 10 mM tetraethylammonium chloride, 2.7 mM glucose, and 10 mM Hepes/NaOH (pH 7.4). The pipette solution contained 95 mM cesium aspartate, 40 mM CsCl, 5 mM NaCl, 1 mM MgCl2, and 10 mM Hepes/NaOH (pH 7.2).
Results
Process outgrowth ofAR42J cells in response to activin A. We studied the effect of activin A on rat pancreatic acinar AR42J cells. After cells were grown in activin A-free medium, 4 nM activin A was added. At this concentration, DNA synthesis in AR42J cells was completely blocked (14) . AR42J cells extended cytoplasmic processes within 72 h of the activin A treatment, and their processes were elongated up until [10] [11] [12] d after the addition of activin A. Many of these processes were several cell diameters in length and growth conelike structures were observed in all of them (Fig. 1 A) . In the absence of activin A, cells continued proliferation and formed aggregation (Fig.  1 B) . The process outgrowth of AR42J was specific to activin A and was not observed by the addition of TGF-,/1 or nerve growth factor (data not shown).
Characterization of antibodies and immunoblotting of neurofilament and MAP-2 in AR42J cells. To elucidate that these extended processes were similar to those of cultured neurons, we analyzed the changes in cytoskeletal architecture. First, we investigated the existence of neuron-specific cytoskeletal proteins by immunoblotting using antibodies directed against the 160-kD subunit of rat NF, a neuron-specific intermediate filament protein, and MAP-2, a neuron-specific high molecular microtubule-associated protein. Fig. 2 bodies. Fig. 3 depicts the time course of AR42J cell differentiation. Activin A-untreated AR42J cells were round in shape, and their amylase-containing secretory vesicles were stained with the antiamylase antibody. Anti-NF antibody also stained their cytoplasm uniformly ( Fig. 3 A and B) . On the second day after the addition of activin A, amylase-containing vesicles decreased moderately, and cells started extending multiple processes, which were labeled with anti-NF antibody (Fig. 3, C  and D) . On the tenth day, no staining of amylase was discernible (Fig. 3 E) , in contrast to the strong staining of the extended processes by anti-NF antibody (Fig. 3 F) . These data document that activin inhibits amylase synthesis in AR42J cells and induces neuronlike process formation containing NF organization. Thus, these results suggest that activin A may induce differentiation from amylase-secreting cells to neuronlike cells. Microtubule organization in activin A-treated AR42J cells. To further characterize the cytoskeletal organization in cytoplasmic processes induced by activin A, we studied changes in microtubule organization by immunocytochemistry using antitubulin antibody. In nonneuronal cultured cells, microtubules were observed as fine filamentous networks emanating from a discrete centralized nucleating structure such as the centrosome. However, in neurons, microtubules formed thick bundles in neurites, and they did not have any discrete origins (30, 31) . In naive AR42J cells, microtubules radiated and formed fine filamentous networks (Fig. 4 A) . It is interesting to note that, in activin A-treated AR42J cells, microtubules tended to form thick bundles. On the third day of activin A treatment, thick bundles were observed in extended process (Fig. 4 B) , and microtubule bundles were detected more remarkably throughout the processes on the tenth day (Fig. 4 C) . These microtubule bundles were not visibly associated with any other cytological structures in the cell body that might serve as microtubule organizing centers (Fig. 4 D) . These data suggest that activin A may induce a change in microtubule organization from nonneuronal to neuronal.
MAP-2 as a component of cross-bridges between microtubules in activin A -induced processes. To further gain an insight into the cytoskeletal similarity between activin A-treated AR42J cells and authentic neurons, we studied the participation of MAP-2 in activin-induced neuritelike processes. Microtubule-associated proteins such as MAP-1, MAP-2, and tau are believed to contribute to the highly differentiated morphology of neurons and to maintain neurites structurally as components of cross-bridges between microtubules (32). MAP-2 in particular is neuron specific and abundant in dendrites (33) . The AR42J cells contained MAP-2 in the cytoplasm before differentiation and in the processes formed after the treatment with activin A (Fig. 5, A and C) . To further elucidate the contribution of MAP-2 to neuronlike differentiation, light and electron mi- 2308 Ohnishi et al. croscopic immunocytochemistry was performed after permeabilization of the cell membrane to wash out soluble proteins. Fig. 5 , B and D, shows indirect immunofluorescence of activinuntreated and -treated AR42J cells for MAP-2 after permeabilization. In activin A-untreated cells, the round cells showed no immunoreactivity (Fig. 5 B) . In activin-treated cells, no signal was observed in the cell bodies, but linear thick bundlelike staining was observed in their processes (Fig. 5 D) . This suggests that MAP-2 may exist solely in soluble form in activin A-untreated AR42J cells, and, after treatment with activin A, a certain amount of MAP-2 may organize Triton X-l00-insoluble bundles of microtubules in neuritelike processes.
To elucidate the participation of MAP-2 within cytoskeletons of the neuritelike processes, we labeled the activin-treated and untreated AR42J cells extracted with Triton X-100 by using anti-MAP-2 antibody followed by immunogold staining. Fig. 6 A shows an activin-treated AR42J cell process labeled with anti-MAP-2 antibody. Microtubules formed many parallel arrays, sug- Figure 6 . Immunoelectron micrographs of neuritelike process in activin A-treated cells and cytoplasm of untreated cells using anti-MAP-2 antibody. AR42J cells were treated with or without 4 nM activin A for 10 d, and immunoelectron micrographs using anti-MAP-2 antibody were obtained as described in Methods. In neuritelike process of activin A-treated cells, microtubules formed bundles and immunoreactivity of MAP-2 were studded between the parallel microtubules (A). In higher magnification observation (A, inset), immunogold particles were shown on cross-bridges between microtubules (arrows). In activin-untreated cells, microtubules never formed bundles and immunogold particles were hardly shown along microtubules (B) . Bars: mains, 200 nm, inset, 40 nm. gesting that microtubules formed bundles, and gold particles were studded between the parallel microtubules. A higher magnification view shows more clearly the localization of most particles on the projecting portions of filamentous fuzzy materials between microtubules (Fig. 6 A, inset) . In naive AR42J cells, microtubules never formed bundles and gold particles were hardly seen along microtubules (Fig. 6 B) . These data suggest that MAP-2 serves as a component of cross-bridges between microtubules in activin-induced processes of AR42J cells. This cytoskeletal architecture closely resembles that of authentic neurons as previously described by Hirokawa et al. (34) .
Effect of activin A on expression of synaptophysin. To expand the morphological evaluation of the effect of activin A on AR42J cells, we examined the secretory vesicle formation by electron microscopy. In activin-treated cells, many small vesicles were observed in the cytoplasm (Fig. 7 A) . In untreated cells, however, such vesicles were rarely observed (Fig. 7 B) . Immunofluorescent microscopy revealed that the number of synaptophysin-containing vesicles was markedly increased in activin-treated cells (Fig. 8, A and B) , and such synaptophysincontaining vesicles were detected in the extended process of activin-treated cells (Fig. 8 A) . The increase in synaptophysin, a marker of synaptic vesicles, was also confirmed by immunoblotting (Fig. 8 C) . Immunohistochemically, neither glucagon nor insulin was detected in activin-treated cells.
Changes in ionic channels expressed in AR42J cells in response to activin A. To determine functional alterations induced by activin A, we investigated the changes in ionic channels expressed in AR42J cells. Previous studies demonstrated that VDCC was expressed in these cells (15) . As shown in Fig. 9 A, a high concentration of potassium induced an elevation of [Ca2" ], an observation consistent with the existence of VDCC in these cells. The peak value of [Ca2"], was 230±56 nM (n = 14). When cells were treated with activin A, the potassiuminduced rise in [Ca2+]c was markedly augmented. Thus, the peak value was 782±113 nM (mean±SE, n = 14). We therefore examined voltage-dependent calcium channel current in activin-treated and untreated cells by whole-cell recording of patch clamp technique. The amplitude of L-type voltage-dependent calcium channel current was not changed significantly after the treatment with activin A (data not shown). We then examined the effect of caffeine on [Ca2" ] to determine the existence of a caffeine-sensitive pool involved in calcium-induced calcium release (CICR). As depicted in Fig. 9 (26) . Competitive RT-PCR revealed that the steady state level of mRNA for the aI subunit of the channel was detected in activin-treated cells (Fig. 10) . It is well known that pancreatic endocrine cells express KATP channel. Antidiabetic drugs, sulfonylureas, inhibit the activity of the KATP channel and thereby depolarize the plasma membrane, which leads to an increase in calcium entry via VDCC. To examine the possibility that AR42J cells express KATP channel, we determined the effect of tolbutamide, a sulfonylurea agent, on [Ca2+]c in a single AR42J cell. . in all of the activin-treated cells tested (n = 18). These results suggest that KATP channels may be expressed in activin-treated cells. To confirm this point, we measured the activity of potassium currents by single channel recording using the patch clamp technique. As depicted in Fig.  12 , burstlike openings of channels were observed in an insideout patch. Openings of at least two channels were observed in this recording, and opening of these channels was almost completely blocked by an addition of ATP in the bath. These results indicated that the currents were due to KATP channel. 
Discussion
The present results demonstrate that the effect of activin A on pancreatic acinar AR42J cells is to extend multiple cytoplasmic processes. We have done cytoskeletal analysis to verify these processes to be neuritelike, whether or not these processes have the distinctive morphology of highly polarized neurites, densynapto- Time (sec) proteins is not surprising. In a previous report, however, immunoreactivity of NFs could not be observed by using commercially available anti-NF antibodies in immunocytochemistry (16) . This may be due to the difference in the sensitivity of the antibodies used in their experiment and ours. Note that we show the existence of 160-kD subunit of NF by immunoblotting as well. After treatment with activin A, AR42J cells begin to extend cytoplasmic processes and contain NF proteins in the processes as in the cell bodies. With regard to the exocrine property, immunoreactivity of amylase decreases and finally disappears as the processes extend (Fig. 3) . These data clearly document the chronological relationship of the expression of characteristics of exocrine and neuronlike cells.
Our data reveal the changes in microtubule organization in AR42J cells treated with activin A. The bundle formation of microtubules is unique in neuron and neuronal cells (38) . Re- drites, and axons (35) . In neurites, microtubules form thick bundles that do not emanate from a microtubule organizing center as in nonneuronal cells (30) . Neuron-specific microtubule-associated proteins such as MAP-1, MAP-2, and tau contribute to the microtubule organization and neurite maintenance by forming cross-bridges between microtubules (32, 33). Neurofilaments, which are neuron-specific intermediate filaments composed of distinct subunit proteins, are another major framework of mammalian neurons (36, 37) . In AR42J cells, 160-kD subunit of NFs and MAP-2 exists in the cytoplasm before the activin A treatment. Since AR42J cells demonstrate neuroendocrine property, containing small vesicles with synaptophysin (16) and molecular devices for uptake and release of y-aminobutylic acid, the expression of these neuron-specific cytoskeletal (41) . An analysis of the molecular properties of VDCC in activin-treated AR42J cells has revealed intriguing information. As shown in Fig. 10 , RT-PCR reveals the expression of mRNA for neuroendocrine//3 cell-type VDCC a, subunit in AR42J cells. This a, subunit is cloned with the PCR method using skeletal muscle VDCC as a guide sequence, and it is shown to be expressed specifically in cells of rat pancreatic islets and considered to play a role in the regulation of insulin secretion (26) . However, it is not expressed in all insulin-secreting cell lines; for example, it is expressed in RINm5F and 3TC-3 cells but not in HIT-T15 cells (26) . Hence, its expression in AR42J cells implies the potential islet cell-like property of activin-treated AR42J cells. Note that neuroendocrine/,/ cell-type VDCC may be a minor component of VDCCs expressed in AR42J, since the treatment with activin A does not significantly alter the amplitude of VDCC current. Tolbutamide is a member of the sulfonylureas and is widely used for the treatment of human diabetes. In cells, tolbutamide binds to the KATP channel or related protein, the sulfonylurea receptor, and inhibits the activity of KATP channels. Resulting depolarization of the plasma membrane leads to opening of VDCC. In activin A-treated AR42J cells, tolbutamide increases
[Ca2+]", while tolbutamide has no effect in nontreated cells.
Moreover, we demonstrate the existence of KATP channel in activin-treated AR42J cells by single channel recording (Fig.   12 ). Hence, AR42J cells express both KATP channel and neuroendocrine/,6 cell-type VDCC a, subunit. Despite the fact that the former is not specific to pancreatic endocrine cells, the expression of two types of channels suggests that activin-treated AR42J cells resemble pancreatic endocrine cells in their electrophysiological characteristics.
Pancreatic endocrine cells, for example, insulin-secreting , / cells, have many properties characteristic of neuronal cells: They extend neurites when cultured in vitro (42); they express various neuroectodermal antigens including tyrosine hydroxylase (43), synaptophysin (44), y-aminobutylic acid transporters, and neuron-specific enolase (45) ; and the plasma membrane of these cells is electrophysiologically excitable. Although pancreatic endocrine cells express neuronal markers, it is generally believed that the pancreatic duct in embryos contains undifferentiated precursor cells that migrate from the duct to originate endocrine and acinar cells (46) . In the embryonic pancreas, putative precursor cells become differentiated and eventually express neuronlike properties. Also, these precursor cells can differentiate into acinar cells. Given that amphicrine AR42J cells become differentiated into acinar-like cells in response to dexamethasone (17) and into neuronlike cells in response to activin A, AR42J cells may provide an in vitro model system to study the differentiation of neuroendocrine and exocrine cells in the pancreas. Despite the fact that AR42J cells are transformed cells, they may be useful to study the differentiation of acinar-like cells in vitro. In this regard, our recent study demonstrates that immunoreactive activin A is expressed in the embryonic pancreatic anlage (47) . It is an interesting possibility that activin A expressed in endocrine precursor cells of the embryonic pancreas may modulate differentiation of the putative precursor cells.
